Shooting Cancer

1 04, 2023

Shooting Cancer Highlights – Monthly focus on regulatory status of new targeted therapies in oncology – February and March 2023

adlitterio663392023-06-28T10:54:57+02:00

2 03, 2023

Shooting Cancer- Highlights Monthly focus on regulatory status of new targeted therapies in oncology – January 2023

adlitterio663392023-03-02T10:17:25+01:00

11 01, 2023

Shooting Cancer- Highlights Monthly focus on regulatory status of new targeted therapies in oncology – November and December 2022

adlitterio663392023-01-11T12:15:44+01:00

10 10, 2022

Shooting Cancer- Highlights Monthly focus on regulatory status of new targeted therapies in oncology – September2022

adlitterio663392022-10-10T13:45:31+02:00

8 09, 2022

Shooting Cancer- Highlights Monthly focus on regulatory status of new targeted therapies in oncology – August 2022

adlitterio663392022-10-10T12:35:57+02:00

4 08, 2022

Shooting Cancer- Highlights Monthly focus on regulatory status of new targeted therapies in oncology – July 2022

adlitterio663392022-08-04T09:43:40+02:00

18 07, 2022

Monthly focus on regulatory status of new targeted therapies in oncology – June 2022

adlitterio663392022-07-18T11:33:44+02:00

14 07, 2022

Monthly focus on regulatory status of new targeted therapies in oncology – June 2022

adlitterio663392022-07-14T13:59:36+02:00

20 05, 2022

Monthly focus on regulatory status of new targeted therapies in oncology – April 2022

Diatech Pharmacogenetics2022-05-20T11:09:53+02:00

12 04, 2022

Monthly focus on regulatory status of new targeted therapies in oncology- March 2022

Diatech Pharmacogenetics2022-04-12T17:26:35+02:00

Vorheriges 123 Nächstes